BioMarin Pharmaceutical Inc (BMRN) stock
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$61.43+2.92 (+4.99%)
Close on Nov 18, 2026Market cap $11.89BP/E 161.7Yield –
BioMarin Pharmaceutical market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BioMarin Pharmaceutical's market cap was $11.29B on Nov 11, 2026, against $10.74B a year earlier. Over the last 5 years it ranged from $10.29B to $21.43B, with a median of $14.37B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $11.29B | -1.1% |
| 2025 | Dec 31, 2025 | $11.42B | -8.9% |
| 2024 | Dec 31, 2024 | $12.53B | -31.0% |
| 2023 | Dec 29, 2023 | $18.16B | -5.6% |
| 2022 | Dec 30, 2022 | $19.23B | +18.6% |
| 2021 | Dec 31, 2021 | $16.22B | +1.9% |
| 2020 | Dec 31, 2020 | $15.92B | +4.8% |
| 2019 | Dec 31, 2019 | $15.19B | +0.2% |
| 2018 | Dec 31, 2018 | $15.15B | -3.2% |
| 2017 | Dec 29, 2017 | $15.65B | +10.0% |
| 2016 | Dec 30, 2016 | $14.22B | -15.8% |
| 2015 | Dec 31, 2015 | $16.89B | +26.7% |
| 2014 | Dec 31, 2014 | $13.33B | +33.2% |
| 2013 | Dec 31, 2013 | $10.00B | +64.3% |
| 2012 | Dec 31, 2012 | $6.09B | +55.2% |
| 2011 | Dec 30, 2011 | $3.92B | +42.2% |
| 2010 | Dec 31, 2010 | $2.76B | +41.6% |
| 2009 | Dec 31, 2009 | $1.95B | – |
See a number that looks wrong?